A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea‐pig bronchus

British Journal of Pharmacology - Tập 134 Số 1 - Trang 30-37 - 2001
Susan J Craib1, Heather C Ellington1, Roger G. Pertwee1, Ruth A. Ross1
1Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland

Tóm tắt

In the absence of indomethacin, anandamide did not contract the guinea‐pig bronchus at concentrations up to 100 μM. In the presence of indomethacin (10 μM), anandamide induced concentration‐related contractions with a pEC50 value of 5.18±0.11. It was significantly less potent than capsaicin (pEC50 7.01±0.1). The anandamide uptake inhibitor AM404, produced only a 14.1±3.22% contraction at 100 μM. All experiments were conducted in the presence of PMSF (20 μM). The vanilloid receptor antagonist, capsazepine (10 μM), significantly attenuated the contractile effect of anandamide, the response to 100 μM anandamide being 40.53±7.04% in the presence of vehicle and 1.57±8.93% in the presence of 10 μM capsazepine. The contractile actions of anandamide and AM404 were markedly enhanced by the peptidase inhibitor thiorphan. The log concentration‐response curve of anandamide was unaltered by the CB1 receptor antagonist, SR141716A. The pEC50 values for anandamide were 4.88±0.08 and 5.17±0.19 in the presence of vehicle and SR141716A (1 μM) respectively. The lipoxygenase inhibitors 5,8,11,14‐eicosatetraynoic acid (ETYA) and 5,8,11 eicosatriynoic acid (ETI) reduced the effect of 100 μM anandamide from 34.7±1.9% (vehicle) to 7.7±5% (ETYA, 10 μM) and from 41.85±4.25% (n=6) (vehicle) to 10.31±3.54 (n=6) (ETI, 20 μM). Neither inhibitor significantly affected contraction of the tissue by substance P. This study provides evidence that anandamide acts on vanilloid receptors in the guinea‐pig isolated bronchus. These data raise the possibility that the contractile action of anandamide may be due, at least in part, to lipoxygenase metabolites of this fatty acid amide that are vanilloid receptor agonists. British Journal of Pharmacology (2001) 134, 30–37; doi:10.1038/sj.bjp.0704223

Từ khóa


Tài liệu tham khảo

10.1016/S0090-6980(00)00053-8

10.1038/35040576

10.1021/jm00074a010

10.1016/0005-2760(77)90221-1

HOLZER P., 1991, Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurones, Pharmacol. Rev., 43, 143

10.1073/pnas.97.11.6155

JERMAN J.C., 2000, The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1), Br. J. Pharmacol. (Proc. Suppl.), 129, 73P

10.1523/JNEUROSCI.19-02-00529.1999

10.1016/0306-3623(94)00292-U

10.1111/j.1476-5381.1991.tb12295.x

10.1111/j.1476-5381.1982.tb09250.x

10.1016/S0014-2999(97)01621-X

10.1016/S0304-3959(97)00213-3

10.1038/sj.bjp.0703850

10.1016/S0090-6980(97)00001-4

10.1038/sj.bjp.0703050

SPINA D., 2000, Effect of the putative vanilloid receptor agonist, anandamide on the baseline tone in the guinea‐pig bronchus, Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol., 7, 60

SZALLASI A., 1999, Vanilloid (capsaicin) receptors and mechanisms, Pharmacol. Rev., 51, 159

10.1007/BF02533870

10.1038/sj.bjp.0703906

10.1016/S0014-2999(00)00207-7

10.1038/22761

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 134 Số 1

30-37

Thông tin tác giả